News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

NIH Awards A USD8.5 Million Contract To Ozgene Pty Ltd


10/19/2005 5:10:34 PM

PERTH, Australia, March 23 /PRNewswire/ -- Ozgene Pty Ltd has been awarded a USD8.5 million contract from the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), to supply Genetically Modified (Knock-out and Knock-In) Mice to the individual investigators in the institute.

This award has been funded in whole or in part with Federal funds from NIAID, NIH, U.S. Department of Health and Human Services, under Contract No. HHSN2722004000013D.

Ozgene's Director & CEO, Dr Frank Koentgen: "We are proud to accept the award and look forward to working with the NIH."

Please go to http://www.ozgene.com/ for more information.

Ozgene Pty Ltd

CONTACT: Contact: Press office: Ozgene Pty Ltd, +61-8-9212-2200 (Phone)


Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES